why choose us

First received: September 06, 2023

Clinical Trial: Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Birch Pollen Allergy

Study Type: INTERVENTIONAL


Official Title: A Phase I Dose Escalation Trial to Investigate the Safety, Tolerability, and Explorative Efficacy, Following Environmental Allergen Exposure in a Chamber, of DM-101PX in Participants With Birch Pollen

Brief Summary: Randomized, double-blind placebo-controlled phase I trial with the primary aim to investigate safety and tolerability of three ascending dosing schemes of DM-101-PX in birch pollen allergic adults.As an explorative objective, the trial will also investigate the effect of DM-101PX on the allergic symptoms following birch pollen allergen exposure in a chamber.Expanded access to the study treatment is not available.

Read more